Study to Assess the Effect of Food on a Single Dose of Acoramidis in Healthy Adult Participants

Completed · Phase 1

Conditions studied: Healthy

In brief

The purpose of this study is to determine the effect of a high-fat, high-caloric meal on the pharmacokinetics (PK) of acoramidis in healthy adult participants following an oral single dose administration of acoramidis. Blood sampling for PK assessment will include measures for acoramidis and its metabolite, acoramidis acyl glucuronide (acoramidis-AG).

Key facts

Study ID

NCT04958135

Run by

Alexion Pharmaceuticals, Inc.

People needed

18

Starts

2021-05-30

Expected to finish

2021-08-04

Last updated by the study team

2026-03-06

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

Where it is running

• Celerion — Lincoln, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.